Detalhe da pesquisa
1.
Reduced metabolic flexibility is a predictor of weight gain among liver transplant recipients.
Liver Transpl
; 30(2): 192-199, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146168
2.
Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients.
Liver Transpl
; 29(9): 979-986, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36847136
3.
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD.
Hepatology
; 76(6): 1811-1824, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35561146
4.
Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease.
Liver Int
; 42(6): 1401-1409, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129295
5.
Association Between Lipoprotein Particles and Atherosclerotic Events in Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol
; 19(10): 2202-2204, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007508
6.
Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity.
Hepatology
; 72(1): 271-286, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32056227
7.
Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu.
Dig Dis Sci
; 66(1): 263-272, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32189102
8.
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.
Hepatology
; 67(2): 534-548, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28696585
9.
Preserved hemostatic status in patients with non-alcoholic fatty liver disease.
J Hepatol
; 65(5): 980-987, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27302378
10.
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease.
Liver Int
; 36(4): 572-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26713759
11.
Validation of noninvasive methods for detecting hepatic steatosis in patients with human immunodeficiency virus infection.
Clin Gastroenterol Hepatol
; 13(2): 402-5, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25004459
12.
Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.
Clin Gastroenterol Hepatol
; 13(5): 1000-8.e3, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25311381
13.
Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (ß-Cell) Function.
Dig Dis Sci
; 60(8): 2529-37, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25784075
14.
Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis.
Gastroenterology
; 145(6): 1271-9.e1-3, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23973920
15.
Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test.
Hepatology
; 50(4): 1175-83, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19670416
16.
The transcontinental variability of nonalcoholic fatty liver disease.
Hepatoma Res
; 62020.
Artigo
em Inglês
| MEDLINE | ID: mdl-36419503
17.
Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein.
J Vis Exp
; (113)2016 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27501005
18.
Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease.
Thromb Res
; 150: 41-43, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28012359